Please turn JavaScript on
Find more feeds
JAMA Current Issue icon

JAMA Current Issue

Want to stay in touch with the latest updates from JAMA Current Issue? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on Specificfeeds.

Reading your RSS feed has never been easier!

Website title: JAMA Network | Home of JAMA and the Specialty Journals of the American Medical Association

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  4.98 / day

Message History

Biomarker-Based Eligibility for Lung Cancer Screening
This study aims to develop and validate a protein-based risk model in individuals with a smoking history from the general population.

Read full story
Hearing Aids for Adults With Mild to Moderate Hearing Loss
This JAMA Insights discusses hearing aids for adults with mild to moderate hearing loss, including hearing aid function and limitations and prescription vs over-the-counter hearing aid devices.

Read full story
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease Research Summary
This study investigated whether low-dose rivaroxaban reduces major adverse cardiovascular events compared with placebo in adults with advanced chronic kidney disease (CKD) stage 4 or 5, including those receiving dialysis.

Read full story
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease
This randomized clinical trial examines the safety and efficacy of low-dose rivaroxaban in the treatment of patients with advanced chronic kidney disease at high risk for cardiovascular events.

Read full story
Rivaroxaban for Cardiovascular Disease Prevention in Chronic Kidney Disease
Cardiovascular disease accounts for approximately half of all deaths among patients with advanced chronic kidney disease (CKD), including those with kidney failure requiring dialysis. Despite this disproportionate burden, effective strategies to prevent and treat cardiovascular disease in this population remain limited. Trials conducted in broader populations, including patients...

Read full story